News Release
You can select the year, month, and category you wish to view.
- All
- Business Development
- Drug Discovery
- General Meeting of Shareholders
- Financial Information
- Other
-
2021.06.24
Notice of Discontinuation of Late stage Phase II Clinical Trial of LT-5001
(126KB)
-
2021.05.24
Notice of Patent Application for LT-1001 (PC-SOD) New Indication
(145KB)
-
2021.04.07
Notice Concerning the Consulting Services Agreement with ASKA Pharmaceutical Holdings Co., Ltd.
(131KB)
-
2021.01.18
Notice on the Outcome of the Project for the Prevention of New Coronavirus Infections
(131KB)
-
2021.01.07
Notice of Discontinuation of late stage Phase II Clinical Trial of LT-5001
(131KB)
-
2020.08.27
Announcement of Late stage Phase II Clinical Trial Results for LT-4002
(254KB)
-
2020.03.24
Notice of Joint Research Agreement with a Pharmaceutical Company
(134KB)
-
2019.11.27
Announcement of the Start of Late stage Phase II Clinical Trial of LT-5001
(142KB)
-
2019.04.26
Announcement of the Start of Late stage Phase II Clinical Trial of LT-4002
(104KB)
-
2019.04.09
Announcement of the start of Phase II clinical trial of LT-5001
(101KB)
